Showing results (21-30 of 116) with videos related to
Sort By:
Pageof 12
Neuropsychiatric Disease and Treatment|October 11, 2023
Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc AnalysisKwonmok Ko, Ben Carter, Anthony J Cleare, et al.Immunogenetics|January 1, 1983
Monoclonal antibody reveals H-2-linked quantitative and qualitative variation in the expression of a Qa-2 region determinantJ Rucker, M Horowitz, E A Lerner, et al.Frontiers in Psychiatry|August 4, 2022
Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic ReviewKwonmok Ko, Gemma Knight, James J Rucker, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 22, 2024
Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022)Emma I Kopra, Jenni Penttinen, James J Rucker, et al.Immunologic Research|February 1, 1997
Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1)B J Doranz, J F Berson, J Rucker, et al.Journal of Affective Disorders|October 9, 2022
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysisKwonmok Ko, Emma I Kopra, Anthony J Cleare, et al.Alimentary Pharmacology & Therapeutics|October 18, 2005
Aerophagia in adults: a comparison with functional dyspepsiaD K Chitkara, A J Bredenoord, M J Rucker, et al.Journal of Neurochemistry|November 5, 1997
Amino-terminal analysis of tryptophan hydroxylase: protein kinase phosphorylation occurs at serine-58S C Kumer, S M Mockus, P J Rucker, et al.Biochemistry|November 24, 1992
Role of internal thermodynamics in determining hydrogen tunneling in enzyme-catalyzed hydrogen transfer reactionsJ Rucker, Y Cha, T Jonsson, et al.Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptorsT L Hoffman, G Canziani, L Jia, et al.Pageof 12